Technology-driven biopharma with a patient-first mindset
Powered by our computing and data platforms, we propel development of novel therapies for patients with rare conditions and other diseases. Our diverse portfolio includes commercialized products and a robust investigational pipeline addressing unmet need in pediatrics, urology, oncology, women’s health, specialty respiratory and infectious diseases.